| 000 | 01147 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516220459.0 | ||
| 264 | 0 | _c20140812 | |
| 008 | 201408s 0 0 eng d | ||
| 022 | _a1471-6771 | ||
| 024 | 7 |
_a10.1093/bja/aeu217 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCoriat, P | |
| 245 | 0 | 0 |
_aCounter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. _h[electronic resource] |
| 260 |
_bBritish journal of anaesthesia _cJul 2014 |
||
| 300 |
_a194-5 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aFluid Therapy _xstandards |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyethyl Starch Derivatives _xstandards |
| 650 | 0 | 4 |
_aPlasma Substitutes _xstandards |
| 650 | 0 | 4 |
_aResuscitation _xstandards |
| 700 | 1 | _aGuidet, B | |
| 700 | 1 | _ade Hert, S | |
| 700 | 1 | _aKochs, E | |
| 700 | 1 | _aKozek, S | |
| 700 | 1 | _aVan Aken, H | |
| 773 | 0 |
_tBritish journal of anaesthesia _gvol. 113 _gno. 1 _gp. 194-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/bja/aeu217 _zAvailable from publisher's website |
| 999 |
_c23931552 _d23931552 |
||